We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$24B
AUM Growth
+$1.05B
Cap. Flow
-$221M
Cap. Flow %
-0.92%
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$114M
2
AET
Aetna Inc
AET
+$96.3M
3
TRV icon
Travelers Companies
TRV
+$94.5M
4
CHK
Chesapeake Energy Corporation
CHK
+$89M
5
AEE icon
Ameren
AEE
+$69.4M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$247M
2
VZ icon
Verizon
VZ
+$186M
3
MDT icon
Medtronic
MDT
+$150M
4
LO
LORILLARD INC COM STK
LO
+$126M
5
JCI icon
Johnson Controls International
JCI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 14.98%
2 Technology 14.23%
3 Financials 12.72%
4 Industrials 11.05%
5 Energy 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRFS
1351
DELISTED
BRF SA
BRFS
$2K ﹤0.01%
108
-200
-65% -$4.52K
JMP
1352
DELISTED
JMP Group LLC
JMP
$2K ﹤0.01%
200
-27,074
-99% -$181K
ADSK icon
1353
Autodesk
ADSK
$52.2B
– –
-83,844
Closed -$4.12M
AFG icon
1354
American Financial Group
AFG
$11.9B
– –
-4,700
Closed -$271K
AGCO icon
1355
AGCO
AGCO
$8.43B
– –
-15,100
Closed -$833K
AIV
1356
Aimco
AIV
$378M
– –
-57,802
Closed -$233K
ANIK icon
1357
Anika Therapeutics
ANIK
$221M
– –
-3,600
Closed -$148K
ARCB icon
1358
ArcBest
ARCB
$3.15B
– –
-7,400
Closed -$273K
BELFB
1359
Bel Fuse Inc Class B
BELFB
$3.57B
– –
-5,600
Closed -$123K
BGFV
1360
DELISTED
Big 5 Sporting Goods
BGFV
– –
-41,200
Closed -$661K
CATO icon
1361
Cato Corp
CATO
$66.5M
– –
-13,872
Closed -$375K
CBT icon
1362
Cabot Corp
CBT
$4.75B
– –
-13,600
Closed -$803K
CLB icon
1363
Core Laboratories
CLB
$468M
– –
-18,000
Closed -$3.57M
CRUS icon
1364
Cirrus Logic
CRUS
$6.88B
– –
-82,500
Closed -$1.64M
CTBI icon
1365
Community Trust Bancorp
CTBI
$1.45B
– –
-16,940
Closed -$639K
DAR icon
1366
Darling Ingredients
DAR
$9.41B
– –
-25,000
Closed -$501K
DECK icon
1367
Deckers Outdoor
DECK
$14.3B
– –
-107,436
Closed -$1.43M
EA icon
1368
Electronic Arts
EA
$52.4B
– –
-77,700
Closed -$2.25M
ESLT icon
1369
Elbit Systems
ESLT
$37B
– –
-25,600
Closed -$1.56M
FCNCA icon
1370
First Citizens BancShares
FCNCA
$24.9B
– –
-929
Closed -$224K
FOLD
1371
DELISTED
Amicus Therapeutics
FOLD
– –
-97,740
Closed -$202K
GERN icon
1372
Geron
GERN
$924M
– –
-213,157
Closed -$419K
GIL icon
1373
Gildan
GIL
$9.59B
– –
-800
Closed -$20K
GL icon
1374
Globe Life
GL
$13.9B
– –
-83,805
Closed -$4.4M
GME icon
1375
GameStop
GME
$9.87B
– –
-921,440
Closed -$9.47M
53 54
55
56 57

Similar funds

PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return

Axa's Q2 2014 Portfolio in Review

As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
  • Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
  • Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
  • Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
  • Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
  • Axa opened 103 new positions and closed 115 in Q2 2014.
  • Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.

Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.